MBL deficiency-causing B allele (rs1800450) as a risk factor for severe COVID-19.

导出 OA

翻译打印收藏纠错

第一作者： Matthaios,Speletas

第一单位： Department of Immunology & Histocompatibility, Faculty of Medicine, University of Thessaly, Larissa, Greece. Electronic address: maspel@med.uth.gr.

作者： Matthaios,Speletas ^[1] ; Katerina,Dadouli ^[2] ; Argyro,Syrakouli ^[3] ; Nikolaos,Gatselis ^[4] ; Georgios,Germanidis ^[5] ; Varvara A,Mouchtouri ^[2] ; Ioannis,Koulas ^[3] ; Anna,Samakidou ^[4] ; Anastasia,Nikolaidou ^[5] ; Aggelos,Stefos ^[4] ; Iordanis,Mimtsoudis ^[5] ; Sophia,Hatzianastasiou ^[6] ; Michalis,Koureas ^[2] ; Lemonia,Anagnostopoulos ^[2] ; Maria,Tseroni ^[6] ; Gerasimina,Tsinti ^[3] ; Symeon,Metallidis ^[5] ; George,Dalekos ^[4] ; Christos,Hadjichristodoulou ^[2]

作者单位： Department of Immunology & Histocompatibility, Faculty of Medicine, University of Thessaly, Larissa, Greece. Electronic address: maspel@med.uth.gr. ^[1] Laboratory of Hygiene and Epidemiology, Faculty of Medicine, University of Thessaly, Larissa, Greece. ^[2] Department of Immunology & Histocompatibility, Faculty of Medicine, University of Thessaly, Larissa, Greece. ^[3] Department of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, Larissa, Greece. ^[4] First Internal Medicine Department, Infectious Diseases Division, AHEPA Hospital, Medical School, Aristotle University of Thessaloniki, Greece. ^[5] National Public Health Organization, Athens, Greece. ^[6]

关键词 COVID-19 MBL deficiency MBL2 genotyping Prognosis SARS-CoV-2